AEterna Zentaris (NASDAQ: AEZS)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-03 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.680 | -0.870 | -0.1900 | ||||
REV | 1.310M | -222.000K | -1.532M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of AEterna Zentaris (NASDAQ: AEZS) through any online brokerage.
There are no as such competitors for AEterna Zentaris.
The latest price target for AEterna Zentaris (NASDAQ: AEZS) was reported by HC Wainwright & Co. on Wednesday, March 30, 2022. The analyst firm set a price target for 1.50 expecting AEZS to fall to within 12 months (a possible -69.82% downside). 2 analyst firms have reported ratings in the last year.
The stock price for AEterna Zentaris (NASDAQ: AEZS) is $4.97 last updated Today at August 8, 2022, 7:28 PM UTC.
There are no upcoming dividends for AEterna Zentaris.
AEterna Zentaris’s Q3 earnings are confirmed for Thursday, November 3, 2022.
There is no upcoming split for AEterna Zentaris.
AEterna Zentaris is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.